- Drug Pipelines
- February 2023
- 35 Pages
Global
From €18412EUR$19,990USD£15,523GBP
- Drug Pipelines
- February 2023
- 33 Pages
Global
From €18412EUR$19,990USD£15,523GBP
- Report
- January 2023
- 123 Pages
Global
From €3219EUR$3,495USD£2,714GBP
- Report
- January 2023
- 97 Pages
Global
From €3219EUR$3,495USD£2,714GBP
- Report
- November 2022
- 82 Pages
Global
From €3219EUR$3,495USD£2,714GBP
- Report
- July 2022
- 56 Pages
Global
From €3680EUR$3,995USD£3,102GBP
- Report
- May 2022
- 167 Pages
Global
From €1796EUR$1,950USD£1,514GBP
- Report
- January 2022
- 41 Pages
Global
From €3680EUR$3,995USD£3,102GBP
- Report
- August 2019
- 212 Pages
Global
From €13811EUR$14,995USD£11,645GBP
- Report
- July 2019
- 46 Pages
Global
From €3680EUR$3,995USD£3,102GBP
- Report
- March 2019
- 164 Pages
Global
From €13811EUR$14,995USD£11,645GBP
- Report
- November 2018
- 43 Pages
Global
From €3680EUR$3,995USD£3,102GBP
- Report
- September 2018
- 162 Pages
Global
From €7364EUR$7,995USD£6,209GBP
- Report
- December 2024
- 145 Pages
Global
From €3638EUR$3,950USD£3,067GBP
- Report
- February 2024
- 129 Pages
Global
From €3914EUR$4,250USD£3,300GBP
- Report
- January 2022
- 119 Pages
Global
From €4099EUR$4,450USD£3,456GBP
- Report
- November 2019
- 115 Pages
Global
From €4099EUR$4,450USD£3,456GBP
- Report
- May 2026
- 90 Pages
China
From €2625EUR$2,850USD£2,213GBP
- Report
- June 2025
- 141 Pages
Global
From €3638EUR$3,950USD£3,067GBP
- Report
- February 2024
- 210 Pages
Global
From €3914EUR$4,250USD£3,300GBP

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more